KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia
Annales d'Endocrinologie · 2026-05 · 87 (3) · 102516
DOI: 10.1016/j.ando.2026.102516 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales d'Endocrinologie, 2026-05. Verfasst von Fanny Chasseloup und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes & Hopital Bicêtre, Service d'Endocrinologie et Maladie de la reproduc…. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Histone Demethylases. Die Arbeit nennt 63 Literaturangaben.
Abstract (Originalsprache)
Patients with primary bilateral macronodular adrenal hyperplasia, recently reclassified as bilateral macronodular adrenal disease (BMAD) have bilateral benign large adrenocortical nodules and variable cortisol excess. BMAD is considered a rare cause of overt Cushing's syndrome but a more frequent cause of bilateral adrenal incidentalomas. Initially considered a sporadic disease, the bilateral nature of the adrenal nodules and familial aggregation suggested a genetic origin. Indeed, genomic studies have improved our understanding of BMAD pathogenesis and identified several genetic events responsible for BMAD. As rare syndromic presentations were described, non-syndromic etiologies were also identified, suggesting distinct molecular backgrounds among BMAD cases. Firstly, germline heterozygous inactivating mutations of the ARMC5 gene, discovered in 2013, are now known to account for around 20-25% of sporadic cases and most familial cases. A second molecular group was later identified, characterized by germline heterozygous pathogenic variants and loss of heterozygosity of the lysine demethylase 1A gene (KDM1A, or LSD1) in familial and sporadic GIP-dependent BMAD, representing less than 5% of BMAD cases. Similarly to ARMC5, the stepwise inactivation of KDM1A, an epigenetic regulator gene, supports a tumor suppressor model of tumorigenesis. The latter, more heterogeneous, molecular group remains globally unelucidated, with the exception of reports of pathogenic variants in genes involved in the PKA and cAMP signaling pathways. In all cases, genetic counseling should be offered to identify affected members and to screen for BMAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes & Hopital Bicêtre, Service d'Endocrinologie et Maladie de la reproduction, 94276 Le Kremlin-Bicêtre, France. Electronic address: fanny.chas…
- Université Paris Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes & Hopital Bicêtre, Service d'Endocrinologie et Maladie de la reproduction, 94276 Le Kremlin-Bicêtre, France; Laboratoire de génétique moléc…
Zitieren
APA
Chasseloup, F., & Kamenický, P. (2026). KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia. Annales d'Endocrinologie, 87(3), 102516. https://doi.org/10.1016/j.ando.2026.102516
Vancouver
Chasseloup F, Kamenický P. KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia. Annales d'Endocrinologie. 2026;87(3):102516. doi:10.1016/j.ando.2026.102516
BibTeX
@article{Chasseloup2026,
author = {Chasseloup, Fanny and Kamenický, Peter},
title = {KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia},
journal = {Annales d'Endocrinologie},
year = {2026},
volume = {87},
number = {3},
pages = {102516},
doi = {10.1016/j.ando.2026.102516}
}
EUVIMED